World DNA Vaccine Market Analysed & Forecast in New RNCOS Study Published at

16 Feb 2016 • by Natalie Aster

LONDON – To date, most vaccines commercialised in the market are intended for use in animals. Nevertheless, growing amount of research focused on the development of DNA vaccines targeting the human clinical segment and ongoing development in the gene delivery techniques have resulted in a rising interest of the leading pharmacos in the market for human DNA vaccines.

Though the number of vaccines for human use is relatively small, their blockbuster sales made the market reach a value of USD 7 billion as of 2014. This is due to increasing awareness, growing R&D investment, and improved clinical outcomes over conventional vaccines.

Furthermore, the degree of penetration of DNA vaccines is higher across the developing nations like India, Brazil, Japan, and China, amid others, owing to uncertainties faced by regulatory systems and decreased spending on a slew of novel therapies. However, efforts have been given up by pharmaceutical giants to expand their R&D activities in emerging markets followed by ensuing marketing and promotion for the native population. At large, the research covers in and out of the DNA Vaccines market which means prime importance to investors.

Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline, Sanofi, Novartis, Zoetis, VGX Animal Health, amid others, are the dominant players in the global market for DNA vaccines.

New research study “Global DNA Vaccine Market Outlook 2020” developed by RNCOS E-Services Pvt. Ltd (RNCOS) provides deep insights into the worldwide DNA vaccines marketplace, giving a complete picture of the 3rd generation vaccine technology. The study offers an all-round analysis of the different DNA vaccines launched by now. The report also provides granular market segmentation in accordance with their end-users into animal and human segments. The therapeutic break-down and geographic segmentation can also be found in the study. The report gives estimates of the market size of the industry for 2014 and provides the future forecast for the industry through 2020. It outlines key market drivers & challenges, trends and developments. Furthermore, the research report explores the competitive landscape and the major market players, shedding light on their commercialised products and providing an analysis of their strengths & weaknesses.

Report Details:

Global DNA Vaccine Market Outlook 2020
Published: February, 2016
Pages: 55
Price: US$ 1,500.00 

More reports by the publisher can be found at RNCOS page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970